|
Bruce
S. Sachais
Assistant Professor, Dept of Pathology and Laboratory Medicine
Director, Biosensor Shared Resource Facility
Cell
Biology and Physiology Program
Address
207 John Morgan
3620 Hamilton Walk
Philadelphia, PA 19104
Office tel.: 215 898-0568
Lab tel.: 215 898-0569
Fax: 215 573-0252
E-mail: sachais@mail.med.upenn.edu
Link(s)
Dr.
Sachais's lab webpage
EDUCATION
Lehigh University: BA (Chemistry), 1988.
Washington University: PhD (Neuroscience), 1996.
Washington University: MD (Medicine), 1996.
|
RESEARCH
INTERESTS
Platelets, Platelet Factor 4, Atherosclerosis, Protein interactions,
Murine models, Transcriptional regulation.
Key
words: Platelets, Platelet Factor
4, Atherosclerosis, Protein interactions, Murine models, Tanscriptional
regulation.

Search PubMed for articles
DESCRIPTION
OF RESEARCH
My laboratory is primarily interested in the biology and
structure of platelet factor 4 (PF4). PF4 is a cationic protein
found in the alpha-granules of platelets and is released upon
platelet activation. It binds avidly to glycosaminoglycans
on the surface of endothelial cells and is known to inhibit
anti-thrombin III, resulting in increased clotting.
We are interested in the role of PF4 in several diseases,
specifically atherosclerosis and heparin induced thrombocytopenia
(HIT). We have found that PF4 is localized in atherosclerotic
lesions and that the presence of PF4 correlated with pathological
and clinical disease progression. Further, we have found that
in vitro PF4 inhibits endocytosis of the LDL receptor, resulting
in decreased LDL degradation and retention of LDL on the cell
surface. Current studies are underway to further understand
the cellular and molecular mechanisms responsible for this
phenomenon and to examine the effects of PF4 on other lipoproteins
and lipoprotein receptors. In vivo experiments are currently
underway to further our understanding of these phenomena.
Another project in the lab is examining the molecular mechanisms
of HIT. This rare but serious complication of heparin therapy
is known to involve the recognition of PF4:heparin complexes
by pathogenic auto-antibodies. It is also known that altering
the ratio of heparin to PF4 alters the recognition of the
complexes. Our working hypothesis is that the structure of
the complexes formed at different heparin:PF4 ratios differs
and that the structural changes are important for the expression
of disease. We are investigating these structural changes
and how these changes effect pathogenesis of HIT. Both in
vitro and in vivo systems are being employed.
RECENT
PUBLICATIONS
Pitsilos, S., Hunt, J.L., Mohler, E.R., 3rd, Prabhakar, A.M.,
Poncz, M., Dawicki, J., Khalapyan, T., Wolfe, M., Fairman,
R., Mitchell, M., Carpnter, J., Golden, M.A., Cines, D.B.,
Sachais, B.S.: Platelet factor 4 localization in carotid atherosclerotic
plaques: Correlation with clinical parameters. Thrombosis
and Haemostasis Vol. 90: 1142-1150, 2003.
Sachais, B.S., Nassar, T., Akkawi, S., Kowalska, M.A., Bdeir,
K., Leitersdorf, E., Hiss, E., Ziporen, L., Aviram, M., Cines,
D., Poncz, M., Higazi, A.A-R: Platelet factor 4 enances the
binding of oxidized low-density lipoprotein to vascular wall
cells. J Biol Chem. Vol. 278: 6187-6193, 2003.
Sachais, B.S., Al-Roof Higazi, A., Cines, D.B., Poncz, M.,
Kowalska, M.A.: Interaction of platelet factor 4 with the
vessel wall. Seminars in Thrombosis and Hemostasis
30(3): 351-358, June 2004.
Rouva, L., Poncz, M., McKenzie, S.E., Reilly, M.P., Arepally,
G., Weisel, J.W., Nagaswami, C., Cines, D.B., and Sachais,
B.S.: Ultralarge Complexes of Heparin and PF4 are Central
to the Pathogenesis of Heparin-Induced Thrombocytopenia. Blood
Vol. 105: 131 - 138, January 2005.
Yu G, Rux AH, Ma P, Bdeir K, Sachais BS: Endothelial expression
of E-selectin is induced by the platelet specific chemokine
Platelet Factor 4 through LRP in an NF-kappaB dependent manner.
Blood Vol. 105: 3545-3551, May 2005.
Lab
ROTATION
PROJECTS
- PF4 activation of NF-kB and resulting pathobiology.
- Structural mapping of monoclonal antibodies to platelet
factor 4
- Transcriptional effects of platelet specific chemokines
- Murine models of atherosclerosis and lipoprotein metabolism
- Lab
personnel:
- Ann Rux, PhD - Lab Manager
Tiffany Turrentine - Research Technician
Rachael Gordon – Undergraduate Student
last updated 7/2006
|